Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShort-Term Debt issuancesShort-Term Debt repayments
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Capital Expenditures (2020 - 2022)

Bio Essence has reported Capital Expenditures over the past 3 years, most recently at -$49851.0 for Q4 2022.

  • Quarterly results put Capital Expenditures at -$49851.0 for Q4 2022, down 155.48% from a year ago — trailing twelve months through Dec 2023 was $92049.0 (down 8.92% YoY), and the annual figure for FY2023 was $3614.0, down 3.42%.
  • Capital Expenditures for Q4 2022 was -$49851.0 at Bio Essence, down from $52053.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for BIOE hit a ceiling of $89847.0 in Q4 2021 and a floor of -$49851.0 in Q4 2022.
  • Median Capital Expenditures over the past 3 years was $9537.0 (2021), compared with a mean of $18206.6.
  • Biggest five-year swings in Capital Expenditures: surged 1463.1% in 2021 and later plummeted 155.48% in 2022.
  • Bio Essence's Capital Expenditures stood at $5748.0 in 2020, then surged by 1463.1% to $89847.0 in 2021, then plummeted by 155.48% to -$49851.0 in 2022.
  • The last three reported values for Capital Expenditures were -$49851.0 (Q4 2022), $52053.0 (Q3 2022), and $89847.0 (Q4 2021) per Business Quant data.